CVS Health runs three main businesses under one roof: ~9,000 retail pharmacies across the US; a pharmacy benefit manager (Caremark) that processes drug claims and negotiates prices on behalf of employers and insurers; and a health insurer (Aetna) covering ~26 million medical members. It also operates primary care clinics through Oak Street Health, targeting Medicare-age patients. Revenue comes from insurance premiums, PBM fees and drug rebates, and retail pharmacy sales.
Employees300,000IPOOct 1, 1952SIC8099HQOne CVS Drive, Woonsocket, RI, USA, 02895
to
Financials (EUR)
Profitability
Metric
Current
Margins
Gross Margin
13.8%
Operating Margin
2.6%
EBITDA Margin
2.5%
Net Margin
0.4%
OCF Margin
—
FCF Margin
2.0%
Returns on Capital
ROE
2.3%
ROA
0.7%
ROIC
4.4%
ROCE
3.2%
ROC (Greenblatt)
18.5%
3Y ROIIC
−21.8%
Consistency
Years Profitable / 10Y
9
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
57.02
Forward P/E
11.27
P/E ex-NRI
11.66
Shiller P/E (CAPE)
15.60
Cash Flow Multiples
P/FCF
12.82
P/OCF
9.41
P/Owner Earnings
33.47
FCF Yield
7.80%
Enterprise Value Multiples
EV / EBIT
32.28
EV / Forward EBIT
11.78
EV / EBITDA
17.20
EV / Forward EBITDA
9.41
EV / Revenue
0.42
EV / Forward Revenue
0.42
Asset / Sales
P/S
0.25
P/B
1.33
P/Tangible Book
—
Growth-Adjusted
PEG
—
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
3.38%
Forward Dividend Yield
3.29%
3Y Dividend Growth
6.5%
Payout Ratio
0.39
5Y Yield on Cost
4.70%
Buybacks & Dilution
3Y Buyback Ratio
0.70%
5Y Share Change
−3.3%
Combined
Shareholder Yield
4.81%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
1.06
Gross Debt / EBITDA
8.11
Cash / Debt
0.13
Equity / Assets
0.30
Coverage
Interest Coverage
3.33
Short-Term Liquidity
Current Ratio
0.84
Quick Ratio
0.63
Cash Ratio
0.12
Composite Scores
Piotroski F-Score
6
Altman Z-Score
2.26
Split History
Date
Split
No split history found.
Ex-date
Amount
Pay date
2026-04-23
$0.665
2026-05-04
2026-01-22
$0.665
2026-02-02
2025-10-23
$0.665
2025-11-03
2025-07-22
$0.665
2025-08-01
2025-04-22
$0.665
2025-05-01
2025-01-23
$0.665
2025-02-03
2024-10-21
$0.665
2024-11-01
2024-07-22
$0.665
2024-08-01
2024-04-19
$0.665
2024-05-01
2024-01-19
$0.665
2024-02-01
10 of 39
View allDate
Transcript
Type
2026-08-05
Q2 2026 CVS Health Corp Earnings Call Transcript
Earnings Call
2026-05-06
Q1 2026 CVS Health Corp Earnings Call Transcript
Earnings Call
2026-03-09
CVS Health Corp at Leerink Global Healthcare Conference Transcript
Conference Presentations
2026-02-10
Q4 2025 CVS Health Corp Earnings Call Transcript
Earnings Call
2025-10-29
Q3 2025 CVS Health Corp Earnings Call Transcript
Earnings Call
2025-07-31
Q2 2025 CVS Health Corp Earnings Call Transcript
Earnings Call
2025-05-01
Q1 2025 CVS Health Corp Earnings Call Transcript
Earnings Call
2025-02-12
Q4 2024 CVS Health Corp Earnings Call Transcript
Earnings Call
2024-11-06
Q3 2024 CVS Health Corp Earnings Call Transcript
Earnings Call
2024-08-07
Q2 2024 CVS Health Corp Earnings Call Transcript
Earnings Call
10 of 64
5-Step DuPont Analysis
ROE %
2.43%
×
×
Net Margin %
0.47%
×
×
Operating Margin %
2.60%
Operating Income
€9.13B
÷
Revenue
€351.16B
×
Tax Burden
0.8131
Net Income
€1.66B
÷
Pretax Income
€2.04B
×
Interest Burden
0.2231
Pretax Income
€2.04B
÷
Operating Income
€9.13B
×
Asset Turnover
1.53
÷
Revenue
€351.16B
÷
Average Total Assets
€229.17B
Begin Total Assets
€241.82B
End Total Assets
€216.52B
×
Equity Multiplier
3.36
÷
Avg Total Assets
€229.17B
÷
Avg Stockholders Equity
€68.20B
Begin Equity
€72.16B
End Equity
€64.23B